213 related articles for article (PubMed ID: 18181167)
1. Serum immunosuppressive acidic protein reflects systemic deterioration of colorectal cancer patient condition.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Watanabe H; Yokoe T; Hiro J; Ojima E; Tanaka K; Kusunoki M
J Surg Oncol; 2008 Apr; 97(5):404-8. PubMed ID: 18181167
[TBL] [Abstract][Full Text] [Related]
2. Preoperative C-reactive protein as a prognostic and therapeutic marker for colorectal cancer.
Koike Y; Miki C; Okugawa Y; Yokoe T; Toiyama Y; Tanaka K; Inoue Y; Kusunoki M
J Surg Oncol; 2008 Dec; 98(7):540-4. PubMed ID: 18937231
[TBL] [Abstract][Full Text] [Related]
3. Serum immunosuppressive acidic protein levels in patients with severe acute pancreatitis.
Shinzeki M; Ueda T; Takeyama Y; Yasuda T; Sawa H; Nakajima T; Matsumoto I; Fujita T; Ajiki T; Fujino Y; Kuroda Y
Pancreas; 2007 Nov; 35(4):327-33. PubMed ID: 18090238
[TBL] [Abstract][Full Text] [Related]
4. Soluble intercellular adhesion molecule-1 as a prognostic marker for stage II colorectal cancer patients.
Toiyama Y; Miki C; Inoue Y; Okugawa Y; Koike Y; Yokoe T; Tanaka K; Kusunoki M
Ann Surg Oncol; 2008 Jun; 15(6):1617-24. PubMed ID: 18368454
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of bcl-2 in patients with colorectal cancer.
Giannoulis K; Fountzilas G; Angouridakis N; Angouridaki C; Giannoulis E; Gamvros O
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s56-8. PubMed ID: 15655644
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of preoperative immunosuppressive acidic protein in patients with gastric carcinoma. Findings from three independent clinical trials. Tumor Marker Committee for the Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Sakamoto J; Teramukai S; Koike A; Saji S; Ohashi Y; Nakazato H
Cancer; 1996 Jun; 77(11):2206-12. PubMed ID: 8635085
[TBL] [Abstract][Full Text] [Related]
7. Are pretreatment serum albumin and cholesterol levels prognostic tools in patients with colorectal carcinoma?
Cengiz O; Kocer B; Sürmeli S; Santicky MJ; Soran A
Med Sci Monit; 2006 Jun; 12(6):CR240-7. PubMed ID: 16733481
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum vascular endothelial growth factor is not a marker for subsequent recurrence during long-term follow-up of colorectal cancer patients.
Roumen RM; Slooter GD; Croiset van Uchelen FA; Huib LV
Dis Colon Rectum; 2005 May; 48(5):1070-5. PubMed ID: 15785896
[TBL] [Abstract][Full Text] [Related]
9. Serum interleukin-6 levels reflect the disease status of colorectal cancer.
Chung YC; Chang YF
J Surg Oncol; 2003 Aug; 83(4):222-6. PubMed ID: 12884234
[TBL] [Abstract][Full Text] [Related]
10. Serum immunosuppressive acidic protein doubling time as a prognostic factor for recurrent renal cell carcinoma after nephrectomy.
Araki K; Igarashi T; Tobe T; Mizoguchi K; Suzuki H; Furuya Y; Ichikawa T; Nakatsu HO; Ito H
Urology; 2006 Dec; 68(6):1178-82. PubMed ID: 17141843
[TBL] [Abstract][Full Text] [Related]
11. Serum level of soluble vascular cell adhesion molecule 1 is a valuable prognostic marker in colorectal carcinoma.
Okugawa Y; Miki C; Toiyama Y; Koike Y; Inoue Y; Kusunoki M
Dis Colon Rectum; 2009 Jul; 52(7):1330-6. PubMed ID: 19571712
[TBL] [Abstract][Full Text] [Related]
12. Significance of postoperative adjuvant immunochemotherapy after curative resection of colorectal cancers: Association between host or tumor factors and survival.
Munemoto Y; Iida Y; Abe J; Saito H; Fujisawa K; Kasahara Y; Mitsui T; Asada Y; Miura S
Int J Oncol; 2002 Feb; 20(2):403-11. PubMed ID: 11788909
[TBL] [Abstract][Full Text] [Related]
13. Serum macrophage-colony stimulating factor levels in colorectal cancer patients correlate with lymph node metastasis and poor prognosis.
Mroczko B; Groblewska M; Wereszczyńska-Siemiatkowska U; Okulczyk B; Kedra B; Łaszewicz W; Dabrowski A; Szmitkowski M
Clin Chim Acta; 2007 May; 380(1-2):208-12. PubMed ID: 17368603
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum vascular endothelial growth factor-a is a marker for subsequent recurrence in colorectal cancer patients.
Alabi AA; Suppiah A; Madden LA; Monson JR; Greenman J
Dis Colon Rectum; 2009 May; 52(5):993-9. PubMed ID: 19502868
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
[TBL] [Abstract][Full Text] [Related]
16. Significance of inflammatory cytokines in the progression of colorectal cancer.
Chung YC; Chang YF
Hepatogastroenterology; 2003; 50(54):1910-3. PubMed ID: 14696431
[TBL] [Abstract][Full Text] [Related]
17. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of immunosuppressive acid protein in genitourinary malignant diseases].
Okada S; Kirime S; Kawasaki T; Kanbara A; Kanehara H; Takasaki N; Miyazaki S; Inai S
Hinyokika Kiyo; 1988 Mar; 34(3):411-8. PubMed ID: 3389287
[TBL] [Abstract][Full Text] [Related]
19. Serum albumin: a prognostic indicator in patients with colorectal cancer.
Heys SD; Walker LG; Deehan DJ; Eremin OE
J R Coll Surg Edinb; 1998 Jun; 43(3):163-8. PubMed ID: 9654876
[TBL] [Abstract][Full Text] [Related]
20. Life-prolonging effect of immunocell BAK (BRM-activated killer) therapy for advanced solid cancer patients: prognostic significance of serum immunosuppressive acidic protein levels.
Ebina T; Ogama N; Shimanuki H; Kubota T; Isono N
Cancer Immunol Immunother; 2003 Sep; 52(9):555-60. PubMed ID: 14627127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
